| 000 | 01378 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517031003.0 | ||
| 264 | 0 | _c20160415 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0125287 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPachnio, Annette | |
| 245 | 0 | 0 |
_aAcyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals. _h[electronic resource] |
| 260 |
_bPloS one _c2015 |
||
| 300 |
_ae0125287 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcyclovir _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus _xgenetics |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Cellular _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhosphoproteins _xgenetics |
| 650 | 0 | 4 |
_aViral Matrix Proteins _xgenetics |
| 700 | 1 | _aBegum, Jusnara | |
| 700 | 1 | _aFox, Ashini | |
| 700 | 1 | _aMoss, Paul | |
| 773 | 0 |
_tPloS one _gvol. 10 _gno. 4 _gp. e0125287 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0125287 _zAvailable from publisher's website |
| 999 |
_c24852634 _d24852634 |
||